Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Oncotarget|September 29, 2018
Ex vivo generation of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigenJoshua N Kellner, Eric Yvon, Simrit ParmarBlood|March 18, 2004
Antigen-induced regulatory T cellsStephane Vigouroux, Eric Yvon, Ettore Biagi, et al.Cytotherapy|July 17, 2016
Improving efficacy of cancer immunotherapy by genetic modification of natural killer cellsRachel A Burga, Tuongvan Nguyen, Jane Zulovich, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for NeuroblastomaRachel A Burga, Eric Yvon, Elizabeth Chorvinsky, et al.Molecular Therapy. Methods & Clinical Development|November 3, 2021
Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemiaScott Raskin, Stacey Van Pelt, Keri Toner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cellsEric Yvon, Michele Del Vecchio, Barbara Savoldo, et al.Bulletin Du Cancer|March 7, 2006
[Immunotherapy of poor-prognosis neuroblastoma in children: from bench to bedside]Raphaël Rousseau, Valérie Combaret, Eric Yvon, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete IL-2 in patients with high-risk neuroblastomaHeidi V Russell, Douglas Strother, Zhuyong Mei, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 2, 2007
Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactinHeidi V Russell, Douglas Strother, Zhuyong Mei, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2008
Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapyYuriko Fujita, Ann M Leen, Jiali Sun, et al.Pageof 4